通过降低CLDN1表达的调节,PABPC3驱动卵巢癌转移和药物敏感性

Hong Zhang1,2, Yiping Lin1, Mintao Ji3

  • 1The First Affiliated Hospital of Soochow University, School of Radiation Medicine and Protection, State Key Laboratory of Radiation Medicine and Protection, Collaborative Innovation Center of Radiation Medicine of Jiangsu Higher Education Institutions, Suzhou Medical College of Soochow University, Suzhou, China.

Cell death & disease
|November 17, 2025
PubMed
概括

聚A结合蛋白细胞质蛋白3 (PABPC3) 驱动卵巢癌转移,并降低患者的存活率. 向PABPC3可能为这种致命的恶性瘤提供了一个新的治疗策略.